thiazoles has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 8 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldus, CD; Bock, J; Hofmann, WK; Kühl, AA; Mochmann, LH; Neumann, M; Nowak, V; Ortiz-Tanchez, J; von der Heide, EK | 1 |
Bertaina, A; Bressanin, D; Cappellini, A; Chiarini, F; Evangelisti, C; Locatelli, F; Lonetti, A; Martelli, AM; McCubrey, JA; Melchionda, F; Pession, A; Spartà, AM | 1 |
Beak, DJ; Bertaina, A; Bittman, R; Chiarini, F; Evangelisti, C; Falconi, M; Locatelli, F; Martelli, AM; McCubrey, JA; Melchionda, F; Pession, A; Pyne, NJ; Pyne, S; Teti, G | 1 |
De Keersmaecker, K; Girardi, T | 1 |
Ito, TK; Kadariya, Y; Pei, J; Sementino, E; Tan, Y; Testa, JR | 1 |
Grunert, M; Jeremias, I; Liebl, J; Menche, D; Müller, R; Schneider, LS; Vick, B; Vollmar, AM; Zhang, S | 1 |
Cools, J; De Keersmaecker, K; Hantschel, O; Superti-Furga, G; Versele, M | 1 |
Beverloo, HB; Cornelissen, JJ; Deenik, W; Valk, PJ; van der Poel-van de Luytgaarde, SC; van Esser, JW; Wattel, MM | 1 |
Chiruvella, KK; Hemlal, H; Joy, O; Moorthy, BT; Raghavan, SC; Ravi, S; Srivastava, M | 1 |
Crombet, O; Lastrapes, K; Morales-Arias, J; Zieske, A | 1 |
10 other study(ies) available for thiazoles and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
ERG induces a mesenchymal-like state associated with chemoresistance in leukemia cells.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Cytarabine; Dasatinib; DNA Repair; Drug Resistance, Neoplasm; Gene Expression Profiling; Humans; K562 Cells; Mesoderm; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Protein-Tyrosine Kinases; Pyrimidines; Signal Transduction; Thiazoles; Trans-Activators; Transcriptional Regulator ERG | 2014 |
Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aurora Kinase A; Aurora Kinase B; Aza Compounds; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Coculture Techniques; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Design; Drug Synergism; G2 Phase Cell Cycle Checkpoints; Humans; Indoles; Jurkat Cells; Mice; Molecular Targeted Therapy; Polo-Like Kinase 1; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Signal Transduction; Thiazoles; Tumor Cells, Cultured | 2014 |
Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Blotting, Western; Cell Line, Tumor; Enzyme Inhibitors; Fingolimod Hydrochloride; Humans; Microscopy, Electron, Transmission; Phosphotransferases (Alcohol Group Acceptor); Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Propylene Glycols; Sphingosine; Thiazoles; Unfolded Protein Response | 2014 |
T-ALL: ALL a matter of Translation?
Topics: Antineoplastic Agents; Cell Cycle Proteins; F-Box Proteins; F-Box-WD Repeat-Containing Protein 7; Gene Expression Regulation, Leukemic; Humans; Hydrazones; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Biosynthesis; PTEN Phosphohydrolase; Receptor, Notch1; Ribosomal Proteins; Ribosomes; Signal Transduction; Thiazoles; Triterpenes; Ubiquitin-Protein Ligases | 2015 |
Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.
Topics: Animals; Apoptosis; Azepines; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Everolimus; Homeodomain Proteins; Imidazoles; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Mice; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Quinolines; Signal Transduction; Thiazoles; Transcription, Genetic; Triazoles; Vincristine | 2015 |
Anti-leukemic effects of the V-ATPase inhibitor Archazolid A.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Immunoblotting; Macrolides; Mice; Mice, Inbred NOD; Mice, SCID; Microscopy, Confocal; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Transfection; Vacuolar Proton-Translocating ATPases; Xenograft Model Antitumor Assays | 2015 |
Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases.
Topics: Benzamides; Dasatinib; Enzyme Activation; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Humans; Imatinib Mesylate; In Vitro Techniques; K562 Cells; Leukemia, Erythroblastic, Acute; Oncogene Proteins, Fusion; Phosphorylation; Piperazines; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; Substrate Specificity; Thiazoles | 2008 |
Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Cytarabine; Dasatinib; Daunorubicin; Granulocyte Colony-Stimulating Factor; Humans; In Situ Hybridization, Fluorescence; Male; Methotrexate; Mitoxantrone; Neoplasm Proteins; Neutropenia; Oncogene Proteins, Fusion; Peripheral Blood Stem Cell Transplantation; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Remission Induction; Splenic Rupture; Thiazoles; Vincristine; Young Adult | 2009 |
Novel rhodanine derivatives induce growth inhibition followed by apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cell Survival; Coloring Agents; DNA Fragmentation; Dose-Response Relationship, Drug; Humans; L-Lactate Dehydrogenase; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species; Rhodanine; Tetrazolium Salts; Thiazoles; Trypan Blue | 2010 |
Complete morphologic and molecular remission after introduction of dasatinib in the treatment of a pediatric patient with t-cell acute lymphoblastic leukemia and ABL1 amplification.
Topics: Child; Dasatinib; Female; Gene Amplification; Humans; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrimidines; Remission Induction; Thiazoles | 2012 |